Natural evolution and surgical outcome of massive subretinal haemorrhage in a patient with neovascular age-related macular degeneration on warfarin therapy.
نویسندگان
چکیده
Foundation item: Supported by Zhejiang Innovation Program for Graduates, China(No.YK2010015) 1Eye Center, Zhejiang Provincial People's Hospital; Eye Institute of Zhejiang Province, Hangzhou 310014, Zhejiang Province, China Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang Province, China Correspondence to: Miao-Qin Wu. Eye Center, Zhejiang Provincial People's Hospital; Eye Institute of Zhejiang Province, Hangzhou 310014, Zhejiang Province, China.doctorwumq@yahoo. com.cn Received: 2011-08-17 Accepted: 2011-10-31
منابع مشابه
Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
INTRODUCTION Neovascular age related macular degeneration (AMD) is relatively uncommon in the black population. We report the 12-month outcome of ranibizumab therapy in five black patients with choroidal neovascular membrane (CNV) secondary to AMD. MATERIAL AND METHODS Retrospective analysis of a prospective audit database maintained for all patients on ranibizumab therapy in a retinal specia...
متن کاملClinical Risk Factors for Poor Anatomic Response to Ranibizumab in Neovascular Age-Related Macular Degeneration§
PURPOSE To identify OCT-based anatomical features and clinical characteristics for poor central retinal thickness (CRT) response to ranibizumab in neovascular age-related macular degeneration (AMD). PATIENTS AND METHODS Investigating our electronic patient records (Eyeswide), patients with neovascular AMD treated with intravitreal injections of 0.5mg/0.05ml ranibizumab were identified and the...
متن کاملEffect of ARMS2 gene polymorphism on intravitreal ranibizumab treatment for neovascular age-related macular degeneration.
Age-related macular degeneration (AMD) is a leading cause of blindness in developed countries. The ARMS2 gene has been found to be associated with AMD. Currently, intravitreal ranibizumab (IVR) treatment is one of the widely used treatments for neovascular AMD. The aim of this study was to investigate the association between the genotype of ARMS2 rs10490924 polymorphism and IVR treatment respon...
متن کاملFeasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration.
PURPOSE To assess the feasibility and potential obstacles of a departmental switch from ranibizumab (Lucentis, Genentech, South San Francisco, CA) to bevacizumab (Avastin, Genentech) for the treatment of neovascular age-related macular degeneration (AMD). METHODS A total of 154 eyes treated for wet AMD with ranibizumab or bevacizumab were examined over a 10-month period. The treatment protoco...
متن کاملNew developments in age-related macular degeneration
Epidemiology and Classification The World Health Organization (WHO) estimates that over 3 million people (9% of global blindness) are blinded by age-related macular degeneration (AMD). AMD affects people over the age of 55. There are two main types of AMD, dry and wet. In dry AMD, patients slowly lose vision through progressive atrophy of the macular tissue. Wet, or exudative, AMD, is associate...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- International journal of ophthalmology
دوره 4 6 شماره
صفحات -
تاریخ انتشار 2011